The NSW government can’t appeal a decision that denied its bid to subpoena the names of 2,316 registered group members in a class action over allegedly unlawful strip searches at music festivals.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
An appeals court has found that a claim by indie duo Angus & Julia Stone alleging their former talent management company owes $2.8 million in overcharges should proceed in a UK court.
The United States has won an appeal in a Darwin-based soldier’s personal injury suit, with the Northern Territory Court of Appeal finidng the US has foreign state immunity from the claims.
The Full Court has found an executive at the company behind the Ultimate Fighting Championship gym franchise should not be on the hook for a $5 million judgment awarded to three franchisees.
On appeal of a $6 million judgment for misleading statements, Dominique Grubisa and her wealth education company DG Institute have argued her advice was based on faulty knowledge, not ill intentions.
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
CBA has attacked two failed class actions’ “misguided” appeal, arguing that requiring companies to disclose incomplete information to shareholders would distort the market.
The Full Court has heard that a judge’s finding on materiality in two failed shareholder class actions against CBA could have “troubling” repercussions for insider trading cases and must be overturned.
Insurer Marsh has wasted no time in appealing a ruling that it breached an obligation not to use documents discovered in litigation over the $7 billion collapse of Greensill in separate proceedings.